Inactivation of the p15 gene in children with acute lymphoblastic leukemia

Sao Paulo Medical Journal

Volumn 121, Issue 5, 2003, Pages 203-206

  Cipolotti, Rosana ^a   Rodrigues Lemos, José Alexandre ^a   Defavery, Ricardo ^a   Scideli, Carlos Alberto ^a   Dal Fabbro, Amaury Lellis ^a   Gonzaga Tone, Luiz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute lymphoblastic leukemia; Lymphoblastic leukemia; p15; Tumor suppressor gene

Indexed keywords

MOLECULAR MARKER; PROTEIN P15;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW EXAMINATION; BRAZIL; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID EXAMINATION; CHILD; CONTROLLED STUDY; EXON; FEMALE; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEQUENCE HOMOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0141891353     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802003000500005     Document Type: Article

References (22)

1. Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1992;28(4):631-9.
2. Stass SA, Mixson J. Oncogenes and tumor suppressor genes: therapeutic implications. Clin Cancer Res 1997;3(12 Pt 2):2687-95.
3. Hunter T, Pines J, Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 1994;79(4):573-82.
4. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371(6494):257-61.
5. Heyman M, Rasool O, Borgonovo Brandter L, et al. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol 1996;14(5):1512-20.
6. Batova A, Diccianni MB, Yu JC, et al. Frequent and selective methylation of p 15 and deletion of both p 15 and p 16 in T-cell acute lymphoblastic leukemia. Cancer Res 1997;57(5):832-6.
7. Maloney KW, McGavran L, Odom LF, Hunger SP. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Leukemia 1998;12(9):1417-21.
8. Brandalise S, Odone V, Pereira W, et al. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group. Leukemia 1993;7:(Suppl 2):S142-5.
9. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplifications of DNA with a thermostable DNA polymerase. Science 1988;239(4839):487-91.
10. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86(8):2766-70.
11. Sambrook J, Fritsch EF, Maniatis J, Molecular Cloning: A Laboratory Manual 2nd ed. Philadelphia: Cold Spring Harbor Laboratory Press; 1989.
12. Rasool O, Heyman M, Brandter LB, et al. p15INK4B and p16INK4 gene inactivation in acute lymphocytic leukemia. Blood 1995;85(12):3431-6.
13. Hebert J, Cayuela JM, Berkeley J, Sigaux F. Candidate tumor suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994;84(12):4038-44.
14. Otsuki T, Clark HM, Wellman A, Jaffe ES, Raffeld M. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995;55(7):1436-40.
15. Okuda T, Shurtleff SA, Valentine MB, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995;85(9):2321-30.
16. Takeuchi S, Bartram CR, Seriu T, et al. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p 18 genes in acute lymphoblastic leukemia of childhood. Blood 1995;86(2)755-60.
17. Iravani M, Dhat R, Price CM. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Oncogene 1997;15(21):2609-14.
18. Hangaishi A, Ogawa S, Imamura N, et al. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2/,MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 1996;87(12):4949-58.
19. Thullberg M, Bartkova J, Khan S, et al. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Lett 2000;470(2):161-6.
20. Guo SX, Taki T, Ohnishi H, et al. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res 2000;24(1):39-46.
21. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000;35(3):317-29.
22. Fink JR, LeBien TW. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Exp Hematol 2001;29(4):490-8.